Injective Secures Regulatory Milestones for Tokenization in US

Can INJ Reach $70 After Injective’s Washington Meetings? - Invest In Crypto News

Injective is making a regulatory push in Washington while its token attempts to build a recovery. The INJ price prediction now has two talking points today, first is a potential move toward $70 and the project’s growing engagement with US financial regulators. Neither promotes immediate bullish reaction coming, but both angles put the spotlight back on Injective. Injective Takes Its Regulatory Ambitions to Washington Injective announced that its…

SEC Memo Shows Injective Discussed Proposed Transfer-Agent Rules With Staff

The Oct. 14 record names CEO Eric Chen among four Injective Labs representatives. Chen met with White House, SEC and CFTC officials in Washington that day.

Can INJ Reach $70 After Injective’s Washington Meetings?

The post Can INJ Reach $70 After Injective’s Washington Meetings? appeared first on Coinpedia Fintech News Injective is making a regulatory push in Washington while its token attempts to build a recovery. The INJ price prediction now has two talking points today, first is a potential move toward $70 and the project’s growing engagement with US financial regulators. Neither promotes immediate bullish reaction coming, but both angles put the spotl…

Injective Secures Regulatory Milestones for Tokenization in US

Injective is expanding its regulatory footprint in the United States as it pushes deeper into tokenized securities and institutional onchain finance. The company said CEO Eric Chen recently met with officials from the White House, SEC and CFTC in Washington alongside members of Injective’s legal, policy and research teams. The meetings come after several regulatory

Injective CEO meets White House, SEC and CFTC officials on onchain finance

Injective CEO Eric Chen met White House, SEC and CFTC officials to advance regulated onchain finance and tokenization of real-world assets.